Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease
| Autor: | Mahrukh Akbar Shaheen, Muhammad Idrees |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Drug
Hepatology biology business.industry Transmission (medicine) media_common.quotation_subject Hepatitis C virus virus diseases Minireviews Disease medicine.disease_cause Virology Immunoglobulin G Telaprevir chemistry.chemical_compound Antigen chemistry Boceprevir Immunology medicine biology.protein business medicine.drug media_common |
| Zdroj: | World Journal of Hepatology. 7:616 |
| ISSN: | 1948-5182 |
| Popis: | Hepatitis C virus (HCV) is a potent human pathogen and is one of the main causes of chronic hepatitis round the world. The present review describes the evidence-based consensus on the diagnosis, prevention and management of HCV disease. Various techniques, for the detection of anti-HCV immunoglobulin G immunoassays, detection of HCV RNA by identifying virus-specific molecules nucleic acid testings, recognition of core antigen for diagnosis of HCV, quantitative antigen assay, have been used to detect HCV RNA and core antigen. Advanced technologies such as nanoparticle-based diagnostic assays, loop-mediated isothermal amplification and aptamers and Ortho trak-C assay have also come to the front that provides best detection results with greater ease and specificity for detection of HCV. It is of immense importance to prevent this infection especially among the sexual partners, injecting drug users, mother-to-infant transmission of HCV, household contact, healthcare workers and people who get tattoos and piercing on their skin. Management of this infection is intended to eradicate it out of the body of patients. Management includes examining the treatment (efficacy and protection), assessment of hepatic condition before commencing therapy, controlling the parameters upon which dual and triple therapies work, monitoring the body after treatment and adjusting the co-factors. Examining the treatment in some special groups of people (HIV/HCV co-infected, hemodialysis patients, renal transplanted patients). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|